Company Number: 12801334

Analysis Date: 2025-07-20 16:08 UTC

Financial Health Assessment of CMB MANAGEMENT LIMITED (FY to 31 Aug 2024)

---

1. Financial Health Score: D

Explanation:
The company’s financial health shows clear signs of distress this year, with a significant drop in net assets and working capital compared to prior periods. While still solvent, the sharp decline in net assets and very tight liquidity position suggest weakened financial resilience, akin to a patient showing symptoms of acute stress and requiring immediate attention to avoid further deterioration.

---

2. Key Vital Signs (Critical Financial Metrics):

Metric	2024 Value (£)	2023 Value (£)	Interpretation
Fixed Assets	549	824	Minimal fixed assets, stable but negligible impact on overall health.
Current Assets	36,474	31,109	Cash and receivables increased, a positive sign of short-term liquidity support.
Current Liabilities	34,855	19,073	Nearly doubled liabilities within a year, a major red flag indicating increased short-term obligations ("symptom of distress").
Net Current Assets	1,619	12,036	Working capital dropped sharply; liquidity buffer is now very thin, indicating a "strained pulse" on operational cash flow.
Total Assets Less Current Liabilities	2,168	12,860	Overall asset buffer shrunk drastically, indicating deteriorating balance sheet strength.
Net Assets / Shareholders’ Funds	872	11,708	Equity eroded by over 90%, a critical sign of "weakening immunity" in financial structure.
Share Capital	1	1	Nominal share capital, standard for a micro company, neutral impact.

---

3. Diagnosis: Financial Condition Overview

CMB MANAGEMENT LIMITED is currently in a fragile financial state, showing a severe decline in net assets and working capital in the latest financial year. Despite stable or slightly increased current assets, the company’s current liabilities surged significantly, squeezing liquidity and threatening the ability to meet short-term obligations comfortably.

The company’s net asset base has diminished from £11,708 in 2023 to just £872 in 2024, a reduction of approximately 93%. This erosion of equity is comparable to a patient losing vital reserves, making the business vulnerable to shocks. The working capital, which acts like the company’s bloodstream to fund day-to-day operations, is dangerously low at £1,619, down from £12,036, indicating potential cash flow stress.

While still solvent and active, the financial "symptoms" suggest the business may be experiencing operational difficulties, possibly due to increased costs, delayed customer payments, or one-off expenses. The company remains a micro-entity with minimal asset base and a single employee (the director), which limits its financial flexibility.

---

4. Recommendations: Path to Financial Wellness

• Immediate Cash Flow Management:
  Conduct a thorough cash flow forecast to identify timing mismatches between receivables and payables. Prioritize collecting outstanding debtors and negotiate extended payment terms with creditors to ease working capital strain.

• Cost Control and Expense Review:
  Scrutinize all operational expenses to identify non-essential costs that can be trimmed or deferred. Reducing overheads will help conserve cash and stabilize finances.

• Capital Injection or Financing:
  Consider a capital injection from the shareholder or seek short-term financing facilities to bolster liquidity and rebuild equity. This will provide a financial cushion and improve confidence among suppliers and stakeholders.

• Monitor Financial Metrics Regularly:
  Set up monthly financial reviews focusing on liquidity ratios and net asset movements to catch early signs of distress and act promptly.

• Strategic Business Review:
  Evaluate the business model, pricing, and market positioning to improve profitability and sustainable cash generation.

• Professional Advice:
  Engage with financial advisors or insolvency practitioners early if cash flow issues persist to explore restructuring options and avoid formal insolvency proceedings.

---

Medical Analogy Summary

The company's financial "vital signs" indicate a patient with an acute liquidity crisis and a rapidly weakening balance sheet "immune system." Immediate interventions to stabilize cash flow and rebuild equity are essential to prevent the company from slipping into more severe financial distress, akin to a medical emergency requiring urgent treatment to restore health.

---